Table 3.
Anti-donor and anti-third-party MLC reactivity, cpm
| α self | α donor | α third | Con A | |
|---|---|---|---|---|
| RH-01 pre | 62 | 4,920 | 6,083 | 5,671 |
| POD 136 | 2,693 | 7,413 | ND | 22,906 |
| POD 276 | 231 | 765 | 4,041 | 9,724 |
| RH-02 pre | 404 | 11,489 | 20,367 | 36,396 |
| POD 34 | 188 | 8,263 | ND | 15,375 |
| POD 174 | 94 | 243 | 12,192 | 18,538 |
| RH-03 pre | 359 | 4,971 | 4,113 | 160,143 |
| POD 50 | 381 | 818 | ND | 14,286 |
| POD 190 | 538 | 139 | 4,681 | 16,378 |
| RH-04 pre | 1,559 | 21,690 | 7,759 | 60,293 |
| POD 51 | 1,493 | 252 | 4,772 | 15,509 |
| RH-05 pre | 349 | 6,028 | 20,562 | 4,284 |
| POD 31 | 683 | 145 | 12,114 | 37,708 |
| RH-07 pre-1 | 741 | 9,109 | ND | 71,171 |
| POD 357 | 285 | 432 | 2,461 | 16,534 |
| RH-07 pre-2 | 354 | 3,905 | 9,367 | 43,932 |
| POD 187 | 229 | 301 | 2,461 | 16,534 |
ND, not determined; pre, before treatment and transplant.